{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:36:12Z","timestamp":1759336572161,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"am","delay-in-days":384,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Pathologie"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.annpat.2022.09.005","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T11:56:14Z","timestamp":1666007774000},"page":"45-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyperplasie lympho\u00efde folliculaire induite par la prise de dasatinib, une entit\u00e9 \u00e0 conna\u00eetre"],"prefix":"10.1016","volume":"43","author":[{"given":"Mona","family":"Phelippeau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Christine","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Syrykh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Ghelfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Carras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lysiane","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9verine","family":"Valmary-Degano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"S1","key":"10.1016\/j.annpat.2022.09.005_bib0125","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/modpathol.2012.176","article-title":"Benign lymphadenopathies","volume":"26","author":"Weiss","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2022.09.005_bib0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.emch.2005.07.001","article-title":"Leuc\u00e9mie my\u00e9lo\u00efde chronique","volume":"2","author":"Leguay","year":"2005","journal-title":"EMC - H\u00e9matologie"},{"key":"10.1016\/j.annpat.2022.09.005_bib0135","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.clinthera.2007.11.005","article-title":"Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"29","author":"Steinberg","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.annpat.2022.09.005_bib0140","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa055229","article-title":"Dasatinib in imatinib-resistant philadelphia chromosome-positive leukemias","volume":"354","author":"Talpaz","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annpat.2022.09.005_bib0145","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","article-title":"European LeukemiaNet 2020\u00a0recommendations for treating chronic myeloid leukemia","volume":"34","author":"Hochhaus","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.annpat.2022.09.005_bib0150","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.clml.2018.03.004","article-title":"Final 3-year results of the dasatinib discontinuation trial in patients with chronic myeloid leukemia who received dasatinib as a second-line treatment","volume":"18","author":"Okada","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.annpat.2022.09.005_bib0155","doi-asserted-by":"crossref","first-page":"e22791","DOI":"10.1097\/MD.0000000000022791","article-title":"Dasatinib associated lymphadenopathy in a chronic myeloid leukemia patient: a case report","volume":"99","author":"Pilalas","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.annpat.2022.09.005_bib0160","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00277-017-3105-8","article-title":"Reactive follicular hyperplasia on dasatinib treatment for chronic myeloid leukemia","volume":"96","author":"Iurlo","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.annpat.2022.09.005_bib0165","doi-asserted-by":"crossref","first-page":"e26597","DOI":"10.1002\/pbc.26597","article-title":"Dasatinib-associated follicular lymphoid hyperplasia: first pediatric case report and literature review","volume":"64","author":"Bouquet","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.annpat.2022.09.005_bib0170","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/bloodadvances.2016003889","article-title":"The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia","volume":"1","author":"Fox","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.annpat.2022.09.005_bib0175","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/PAS.0000000000000488","article-title":"Dasatinib-related follicular hyperplasia: an underrecognized entity with characteristic morphology","volume":"39","author":"Ozawa","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2022.09.005_bib0180","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000375150","article-title":"Lymphoproliferative disorders in patients with chronic myeloid leukemia: a single-center case series","volume":"134","author":"Alshehry","year":"2015","journal-title":"Acta Haematol"},{"key":"10.1016\/j.annpat.2022.09.005_bib0185","article-title":"Case report of dasatinibinduced follicular lymphoid hyperplasia","author":"Knott","year":"2014","journal-title":"AVAHO Meeting"},{"key":"10.1016\/j.annpat.2022.09.005_bib0190","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood-2013-07-513879","article-title":"Reversible lymph node follicular hyperplasia associated with dasatinib treatment of chronic myeloid leukemia in chronic phase","volume":"122","author":"Roux","year":"2013","journal-title":"Blood"},{"year":"2007","series-title":"Pathologie ganglionnaire non tumorale","author":"Jos\u00e9e Audouin","key":"10.1016\/j.annpat.2022.09.005_bib0195"},{"key":"10.1016\/j.annpat.2022.09.005_bib0200","doi-asserted-by":"crossref","unstructured":"Lymphadenitis and Lymphadenopathy. In: Monographs in Clinical Cytology [Internet]. S. Karger AG; 2018 [cit\u00e9 30\u00a0ao\u00fbt 2021]. p. 19-33. Disponible sur: https:\/\/www.karger.com\/Article\/FullText\/478879.","DOI":"10.1159\/000478879"},{"key":"10.1016\/j.annpat.2022.09.005_bib0205","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.semdp.2017.11.015","article-title":"Autoimmune and medication-induced lymphadenopathies","volume":"35","author":"Gru","year":"2018","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.annpat.2022.09.005_bib0210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.semdp.2017.05.002","article-title":"A pattern-based approach to reactive lymphadenopathies","volume":"35","author":"Tzankov","year":"2018","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.annpat.2022.09.005_bib0215","article-title":"Drug-induced hypersensitivity syndrome: a clinical, radiologic, and histologic mimic of lymphoma","volume":"2018","author":"Gowani","year":"2018","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.annpat.2022.09.005_bib0220","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3389\/fphar.2019.01340","article-title":"Immediate effects of dasatinib on the migration and redistribution of na\u00efve and memory lymphocytes associated with lymphocytosis in chronic myeloid leukemia patients","volume":"10","author":"Colom-Fern\u00e1ndez","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.annpat.2022.09.005_bib0225","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/leu.2009.46","article-title":"Clonal expansion of T\/NK-cells during tyrosine kinase inhibitor dasatinib therapy","volume":"23","author":"Mustjoki","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.annpat.2022.09.005_bib0230","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00428-019-02681-y","article-title":"Novel markers in pediatric-type follicular lymphoma","volume":"475","author":"Agostinelli","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1016\/j.annpat.2022.09.005_bib0235","first-page":"864","article-title":"Frequency of bcl-2\u00a0expression in non-Hodgkin's lymphoma: a study of 778\u00a0cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia","volume":"11","author":"Lai","year":"1998","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"10.1016\/j.annpat.2022.09.005_bib0120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1684\/ejd.2016.2954","article-title":"Pathological findings of lymphadenopathy in drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic syndrome (DRESS): similarities with angioimmunoblastic T-cell lymphoma","volume":"27","author":"Sato","year":"2017","journal-title":"Eur J Dermatol"}],"container-title":["Annales de Pathologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649822001754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649822001754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:35:33Z","timestamp":1759332933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0242649822001754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0242649822001754"],"URL":"https:\/\/doi.org\/10.1016\/j.annpat.2022.09.005","relation":{},"ISSN":["0242-6498"],"issn-type":[{"type":"print","value":"0242-6498"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperplasie lympho\u00efde folliculaire induite par la prise de dasatinib, une entit\u00e9 \u00e0 conna\u00eetre","name":"articletitle","label":"Article Title"},{"value":"Annales de Pathologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annpat.2022.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}